First case of homozygous C1 inhibitor deficiency.

[1]  M. López-Trascasa,et al.  Hereditary angioedema: The mutation spectrum of SERPING1/C1NH in a large Spanish cohort , 2005, Human mutation.

[2]  M. López-Trascasa,et al.  Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in Spain. , 2005, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[3]  A. Tordai,et al.  Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond , 2004, Journal of Allergy and Clinical Immunology.

[4]  William H. Yang,et al.  Canadian 2003 International Consensus Algorithm For the Diagnosis, Therapy, and Management of Hereditary Angioedema. , 2004, The Journal of allergy and clinical immunology.

[5]  N. Thielens,et al.  Structure and activation of the C1 complex of complement: unraveling the puzzle. , 2004, Trends in immunology.

[6]  M. Cicardi,et al.  Autoantibodies and Lymphoproliferative Diseases in Acquired C1-Inhibitor Deficiencies , 2003, Medicine.

[7]  K. Bork,et al.  Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. , 2003, Archives of internal medicine.

[8]  E. López-Granados,et al.  Detection of C1 inhibitor (SERPING1/C1NH) mutations in exon 8 in patients with hereditary angioedema: evidence for 10 novel mutations , 2002, Human mutation.

[9]  J. Whisstock,et al.  The Serpins Are an Expanding Superfamily of Structurally Similar but Functionally Diverse Proteins , 2001, The Journal of Biological Chemistry.

[10]  K. Bork,et al.  Asphyxiation by laryngeal edema in patients with hereditary angioedema. , 2000, Mayo Clinic proceedings.

[11]  C. Hack,et al.  C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema. , 2000, Pharmacological reviews.

[12]  M. Tosi.  Molecular genetics of C1 inhibitor. , 1998, Immunobiology.

[13]  A. Davis,et al.  Role of the P2 residue of complement 1 inhibitor (Ala443) in determination of target protease specificity: inhibition of complement and contact system proteases. , 1997, Journal of immunology.

[14]  E. Verpy,et al.  Exhaustive mutation scanning by fluorescence-assisted mismatch analysis discloses new genotype-phenotype correlations in angiodema. , 1996, American journal of human genetics.

[15]  H. Wright,et al.  Structural basis for serpin inhibitor activity , 1995, Proteins.

[16]  M. Cicardi,et al.  Hereditary and Acquired C1‐Inhibitor Deficiency: Biological and Clinical Characteristics in 235 Patients , 1992, Medicine.

[17]  G. Arlaud,et al.  Isolation and functional characterization of the proenzyme form of the catalytic domains of human C1r. , 1989, The Biochemical journal.

[18]  F. Rosen,et al.  Genetically determined heterogeneity of the C1 esterase inhibitor in patients with hereditary angioneurotic edema. , 1971, The Journal of clinical investigation.

[19]  F. Rosen,et al.  Hereditary Angioneurotic Edema: Two Genetic Variants , 1965, Science.

[20]  C. Hack,et al.  Clearance of human native, proteinase-complexed, and proteolytically inactivated C1-inhibitor in rats. , 1993, Blood.